Gene expression dynamics during diabetic periodontitis

Journal of Dental Research

Volumn 91, Issue 12, 2012, Pages 1160-1165

  Andriankaja, O M ^a,b   Galicia, J ^a   Dong, G ^a   Xiao, W ^a,c   Alawi, F ^a   Graves, D T ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^c PEKING UNIVERSITY SCHOOL AND HOSPITAL OF STOMATOLOGY   (China)

Author keywords

DAVID; diabetes; GSEA; inflammation; microarray; periodontal disease(s)

Indexed keywords

MACROGOL DERIVATIVE; MESSENGER RNA; PEGYLATED SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR I; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANIMAL; ARTICLE; DISEASE MODEL; DRUG ANTAGONISM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MALE; METABOLISM; METABOLOME; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIODONTITIS; PERIODONTIUM; RAT; WISTAR RAT;

ANIMALS; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MALE; METABOLOME; PERIODONTITIS; PERIODONTIUM; POLYETHYLENE GLYCOLS; RATS; RATS, WISTAR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84872940145     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034512465292     Document Type: Article

References (32)

1. Alblowi J, Kayal RA, Siqueira M, McKenzie E, Krothapalli N, McLean J, et al. High levels of tumor necrosis factor-alpha contribute to accelerated loss of cartilage in diabetic fracture healing. Am J Pathol. 2009 ; 175: 1574-1585
2. Behl Y, Krothapalli P, Desta T, Roy S, Graves DT. FOXO1 plays an important role in enhanced microvascular cell apoptosis and microvascular cell loss in type 1 and type 2 diabetic rats. Diabetes. 2009 ; 58: 917-925
3. Belfort R, Berria R, Cornell J, Cusi K. Fenofibrate reduces systemic inflammation markers independent of its effects on lipid and glucose metabolism in patients with the metabolic syndrome. J Clin Endocrinol Metab. 2010 ; 95: 829-836
4. Benakanakere M, Kinane DF. Innate cellular responses to the periodontal biofilm. Front Oral Biol. 2012 ; 15: 41-55
5. Gene Portal System.. 2009 ;:
6. Chauhan N, Taliyan R, Sharma PL. Effect of dipyrone and thalidomide alone and in combination on STZ-induced diabetic neuropathic pain. Naunyn Schmiedebergs Arch Pharmacol. 2012 ; 385: 527-538
7. Delerive P, De Bosscher K, Besnard S, Vanden Berghe W, Peters JM, Gonzalez FJ, et al. Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. J Biol Chem. 1999 ; 274: 32048-32054
8. DiPetrillo K, Coutermarsh B, Gesek FA. Urinary tumor necrosis factor contributes to sodium retention and renal hypertrophy during diabetes. Am J Physiol Renal Physiol. 2003 ; 284: F113 - F121
9. Franquinho F, Liz MA, Nunes AF, Neto E, Lamghari M, Sousa MM. Neuropeptide Y and osteoblast differentiation - the balance between the neuro-osteogenic network and local control. FEBS J. 2010 ; 277: 3664-3674
10. Gacka M, Dobosz T, Szymaniec S, Bednarska-Chabowska D, Adamiec R, Sadakierska-Chudy A. Proinflammatory and atherogenic activity of monocytes in type 2 diabetes. J Diabetes Complications. 2010 ; 24: 1-8
11. Galindo RC, Munoz PM, de Miguel MJ, Marin CM, Blasco JM, Gortazar C, et al. Differential expression of inflammatory and immune response genes in rams experimentally infected with a rough virulent strain of. Brucella ovis. Vet Immunol Immunopathol. 2009 ; 127: 295-303
12. Garlet GP, Cardoso CR, Campanelli AP, Ferreira BR, Avila-Campos MJ, Cunha FQ, et al. The dual role of p55 tumour necrosis factor-alpha receptor in Actinobacillus actinomycetemcomitans-induced experimental periodontitis: host protection and tissue destruction. Clin Exp Immunol. 2007 ; 147: 128-138
13. Goren I, Muller E, Schiefelbein D, Christen U, Pfeilschifter J, Muhl H, et al. Systemic anti-TNFalpha treatment restores diabetes-impaired skin repair in ob/ob mice by inactivation of macrophages. J Invest Dermatol. 2007 ; 127: 2259-2267
14. Goto T, Nakao K, Gunjigake KK, Kido MA, Kobayashi S, Tanaka T. Substance P stimulates late-stage rat osteoblastic bone formation through neurokinin-1 receptors. Neuropeptides. 2007 ; 41: 25-31
15. Grant MM, Creese AJ, Barr G, Ling MR, Scott AE, Matthews JB, et al. Proteomic analysis of a noninvasive human model of acute inflammation and its resolution: the twenty-one day gingivitis model. J Proteome Res. 2010 ; 9: 4732-4744
16. Graves DT, Liu R, Alikhani M, Al-Mashat H, Trackman PC. Diabetes-enhanced inflammation and apoptosis - impact on periodontal pathology. J Dent Res. 2006 ; 85: 15-21
17. Graves DT, Li J, Cochran DL. Inflammation and uncoupling as mechanisms of periodontal bone loss. J Dent Res. 2011 ; 90: 143-153
18. Hasturk H, Kantarci A, Van Dyke TE. Paradigm shift in the pharmacological management of periodontal diseases. Front Oral Biol. 2012 ; 15: 160-176
19. Huang H, Gandhi JK, Zhong X, Wei Y, Gong J, Duh EJ, et al. TNFalpha is required for late BRB breakdown in diabetic retinopathy, and its inhibition prevents leukostasis and protects vessels and neurons from apoptosis. Invest Ophthalmol Vis Sci. 2011 ; 52: 1336-1344
20. Kayal RA, Siqueira M, Alblowi J, McLean J, Krothapalli N, Faibish D, et al. TNF-alpha mediates diabetes-enhanced chondrocyte apoptosis during fracture healing and stimulates chondrocyte apoptosis through FOXO1. J Bone Miner Res. 2010 ; 25: 1604-1615
21. Liu R, Bal HS, Desta T, Krothapalli N, Alyassi M, Luan Q, et al. Diabetes enhances periodontal bone loss through enhanced resorption and diminished bone formation. J Dent Res. 2006 ; 85: 510-514
22. Mealey BL, Oates TW. Diabetes mellitus and periodontal diseases. J Periodontol. 2006 ; 77: 1289-1303
23. Naguib G, Al-Mashat H, Desta T, Graves DT. Diabetes prolongs the inflammatory response to a bacterial stimulus through cytokine dysregulation. J Invest Dermatol. 2004 ; 123: 87-92
24. Offenbacher S, Barros SP, Paquette DW, Winston JL, Biesbrock AR, Thomason RG, et al. Gingival transcriptome patterns during induction and resolution of experimental gingivitis in humans. J Periodontol. 2009 ; 80: 1963-1982
25. Pacios S, Kang J, Galicia J, Gluck K, Patel H, Ovaydi-Mandel A, et al. Diabetes aggravates periodontitis by limiting repair through enhanced inflammation. FASEB J. 2012 ; 26: 1423-1430
26. Paiva RT, Saliba AM, Fulco TO, de Souza Sales J, Serra de Carvalho D, Sampaio EP, et al. A framework to identify gene expression profiles in a model of inflammation induced by lipopolysaccharide after treatment with thalidomide. BMC Res Notes. 2012 ; 5: 292
27. Sagara M, Satoh J, Wada R, Yagihashi S, Takahashi K, Fukuzawa M, et al. Inhibition of development of peripheral neuropathy in streptozotocin-induced diabetic rats with N-acetylcysteine. Diabetologia. 1996 ; 39: 263-269
28. Sfikakis PP, Markomichelakis N, Theodossiadis GP, Grigoropoulos V, Katsilambros N, Theodossiadis PG. Regression of sight-threatening macular edema in type 2 diabetes following treatment with the anti-tumor necrosis factor monoclonal antibody infliximab. Diabetes Care. 2005 ; 28: 445-447
29. Siqueira MF, Li J, Chehab L, Desta T, Chino T, Krothpali N, et al. Impaired wound healing in mouse models of diabetes is mediated by TNF-alpha dysregulation and associated with enhanced activation of forkhead box O1 (FOXO1). Diabetologia. 2010 ; 53: 378-388
30. van Bilsen M, van Nieuwenhoven FA. PPARs as therapeutic targets in cardiovascular disease. Expert Opin Ther Targets. 2010 ; 14: 1029-1045
31. WuCOrozcoCBoyerJLegliseMGoodaleJBatalovS. (2009). BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol10:R130. doi:10.1186/gb-2009-10-11-r130. Found at http://biogps.org
32. Wu CC, Chen JS, Lu KC, Chen CC, Lin SH, Chu P, et al. Aberrant cytokines/chemokines production correlate with proteinuria in patients with overt diabetic nephropathy. Clin Chim Acta. 2010 ; 411: 700-704